Harvard Bioscience reports Q4 revenue of $23.7M, outlines growth strategy
Go back to Harvard Bioscience reports Q4 revenue of $23.7M, outlines growth strategy| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 8.03 -0.12 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.15 | 52 Week High | $3.90 | |||
| Open | $8.18 | 52 Week Low | $2.25 | |||
| Day High | $8.18 | P/E | N/A | |||
| Day Low | $8.02 | EPS | $-0.03 | |||
| Volume | 8,347 | |||||
